Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas H G Holford

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Therapeutic Drug Monitoring|November 23, 2013
Response to Diaz and de Leon "the mathematics of drug dose individualization should be built with random effects linear models"Nicholas H G Holford, Thierry Buclin
Therapeutic Drug Monitoring|September 11, 2012
Safe and effective variability-a criterion for dose individualizationNicholas H G Holford, Thierry Buclin
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's diseaseRobert A Hauser, Nicholas H G Holford
Clinical Pharmacology and Therapeutics|April 17, 2002
Determination of maximum effectLewis B Sheiner, Nicholas H G Holford
European Journal of Clinical Pharmacology|May 19, 2004
No urine, no urinary clearanceBrian J Anderson, Nicholas H G Holford
Pharmaceutical Statistics|November 26, 2008
Washout and delayed start designs for identifying disease modifying effects in slowly progressive diseases using disease progression analysisBerend Arnold Ploeger, Nicholas H G Holford
British Journal of Clinical Pharmacology|September 11, 2008
Population pharmacokinetic and pharmacodynamic modelling of the effects of nicorandil in the treatment of acute heart failureSatofumi Iida, Haruki Kinoshita, Nicholas H G Holford
British Journal of Clinical Pharmacology|July 9, 2002
Clinical pharmacology: principles and practice of drug therapy in medical educationBrian Whiting, Nicholas H G Holford, Evan J Begg
European Journal of Pediatrics|June 30, 2006
Population clinical pharmacology of children: general principlesBrian J Anderson, Karel Allegaert, Nicholas H G Holford
European Journal of Pediatrics|June 30, 2006
Population clinical pharmacology of children: modelling covariate effectsBrian J Anderson, Karel Allegaert, Nicholas H G Holford
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|November 23, 2013
Response to Diaz and de Leon "the mathematics of drug dose individualization should be built with random effects linear models"Nicholas H G Holford, Thierry Buclin
Therapeutic Drug Monitoring|September 11, 2012
Safe and effective variability-a criterion for dose individualizationNicholas H G Holford, Thierry Buclin
Movement Disorders : Official Journal of the Movement Disorder Society|October 3, 2002
Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's diseaseRobert A Hauser, Nicholas H G Holford
Clinical Pharmacology and Therapeutics|April 17, 2002
Determination of maximum effectLewis B Sheiner, Nicholas H G Holford
European Journal of Clinical Pharmacology|May 19, 2004
No urine, no urinary clearanceBrian J Anderson, Nicholas H G Holford
Pharmaceutical Statistics|November 26, 2008
Washout and delayed start designs for identifying disease modifying effects in slowly progressive diseases using disease progression analysisBerend Arnold Ploeger, Nicholas H G Holford
British Journal of Clinical Pharmacology|September 11, 2008
Population pharmacokinetic and pharmacodynamic modelling of the effects of nicorandil in the treatment of acute heart failureSatofumi Iida, Haruki Kinoshita, Nicholas H G Holford
British Journal of Clinical Pharmacology|July 9, 2002
Clinical pharmacology: principles and practice of drug therapy in medical educationBrian Whiting, Nicholas H G Holford, Evan J Begg
European Journal of Pediatrics|June 30, 2006
Population clinical pharmacology of children: general principlesBrian J Anderson, Karel Allegaert, Nicholas H G Holford
European Journal of Pediatrics|June 30, 2006
Population clinical pharmacology of children: modelling covariate effectsBrian J Anderson, Karel Allegaert, Nicholas H G Holford
Pageof 5